Lansium domesticum: Skin and leaf extracts of this fruit tree interrupt the lifecycle of Plasmodium falciparum, and are active towards a chloroquine-resistant strain of the parasite (T9) in vitro

Journal of Ethnopharmacology

Volumn 85, Issue 1, 2003, Pages 145-150

  Yapp, Donald T T ^a,b   Yap, S Y ^a  

^a UNIVERSITI MALAYSIA SARAWAK   (Malaysia)

^b BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

Author keywords

Chloroquine resistance; Lansium domesticum; Malaria; Plasmodium falciparum; T9

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; LANSIUM DOMESTICUM EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIMALARIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; FRUIT; IN VITRO STUDY; LANSIUM DOMESTICUM; LIFE CYCLE; MALARIA FALCIPARUM; NONHUMAN; PLANT LEAF; PLANT SEED; PLASMODIUM FALCIPARUM; TREE;

LANSIUM DOMESTICUM; PLASMODIUM FALCIPARUM;

EID: 0037358279     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-8741(02)00375-6     Document Type: Article

References (26)

1. Ang H.C., Chan K.L., Mak J.W. Quantitative assessment of antimalarial activities from Malaysian Plasmodium falciparum isolates by modified in vitro microtechnique. Antimicrobial Agents and Chemotherapy. 39:1995;626-628.
2. Balint G.A. Artemisinin and its derivatives: an important new class of antimalarial agents. Pharmacology and Therapeutics. 90:2001;261-265.
3. Breman J.G. The ears of the hippopotamus: manifestations, determinants, and estimates of the malaria burden. American Journal of Tropical Medicine and Hygiene. 64:2001;1-11.
4. Cragg G.M., Newman D.J., Snader K.M. Natural products in drug discovery and development. The Journal of Natural Products. 60:1997;52-60.
5. Foley M., Tilley L. Quinoline antimalarials: mechanisms of action and resistance and prospects for new agents. Pharmacology and Therapeutics. 1:1998;55-87.
6. Gilles, H.M., 1993. The malaria parasites. In: Gilles, H.M., Warrell, D.A. (Eds.), Bruce-Chwatt's Essential Malariology, 3rd ed. Edward Arnold, Great Britain, pp. 12-34.
7. Harvey A.L. Medicines from nature: are natural products still relevant to drug discovery? Trends in Pharmacological Sciences. 20:1999;196-198.
8. Hyde J.E. Mechanisms of resistance of Plasmodium falciparum to antimalarial drugs. Microbes and Infection. 4:2002;165-174.
9. Kirby G.C. Medicinal plants and the control of parasites. Transactions of the Royal Society of Tropical Medicine and Hygiene. 90:1996;60-609.
10. Kirby G.C. Plants as a source of antimalarial drugs. Tropical Doctor. 27:1997;7-11.
11. Lambros C., Vanderberg J.P. Synchronization of Plasmodium falciparum erythrocyte stages in culture. Journal of Parasitology. 65:1979;418-420.
12. Meshnick S.R., Taylor T.E., Kamchonwongpaisan S. Artemesinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy. Microbiology Reviews. 60:1996;301-315.
13. Morton, J., 1987. Fruits of Warm Climates. J.F.M., Miami, p. 201.
14. Nishizawa M., Nademoto Y., Sastrapradja S., Shiro M., Hayahi Y. Dukunolide D, E and F: new tetranortriterpenoids from the seeds of Lansium domesticum. Phytochemistry. 27:1988;237-239.
15. Nishizawa M., Emura M., Yamada H., Shiro M., Chairul, Yuji H., Tokuda H. Isolation of a new cycloartanoid triterpene from leaves of Lansium domesticum: novel skin-tumor promotion inhibitors. Tetrahedron Letters. 30:1989;5616-5618.
16. Nosten F., van Vugt M., Price R., Luxemburger C., Thway K.L., Brockman A., McGready R., ter Kuile F. Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in Western Thailand: a prospective study. Lancet. 356:2000;297-302.
17. Onori, E., Beales, P.F., Gilles, H.M., 1993. From malaria eradication to malaria control: the past, the present and the future. In: Gilles, H.M., Warrell, D.A. (Eds.), Bruce-Chwatt's Essential Malariology, 3rd ed. Edward Arnold, Great Britain, pp. 267-282.
18. Rieckmann K.H., Campbell G.H., Sax L.J., Mrema J.E. Drug sensitivity of Plasmodium falciparum: an in vitro microtechnique. The Lancet. January 7:1978;22-23.
19. Trager W., Jensen J.B. Human malaria parasites in continuous culture. Science. 193:1976;673-675.
20. van Agtmael M.A., Eggelte T.A., Boxtel C.J. Artemesinin drugs in the treatment of malaria: from medicinal herb to registered medication. Trends in Pharmacological Sciences. 20:1999;199-205.
21. White N.J., Olliaro P.L. Strategies for the prevention of antimalarial drug resistance: rationale for combination chemotherapy for malaria. Parasitology Today. 12:1996;399-401.
22. Winstanley P.A. Chemotherapy for falciparum malaria: the armoury, the problem and the prospects. Parasitology Today. 16:2000;146-153.
23. Winstanley P.A. Modern chemotherapeutic options for malaria. The Lancet Infectious Diseases. 1:2001;242-250.
24. Winstanley P.A., Ward S.A., Snow R.W. Clinical status and implications of antimalarial drug resistance. Microbes and Infection. 4:2002;157-164.
25. Wongsrichanalai C., Pickard A.L., Wernsdorfer W.H., Meshnick S.R. Epidemiology of drug resistant malaria. Lancet Infectious Diseases. 2:2002;209-218.
26. Yapp D.T.T., Steed J., Yap S.Y., Houghton P.J. The isolation and structural characterization of n-methyl-4-hydroxyproline from the fruit skin of Lansium spp. Crystallographic Acta E. 58:2002;988-989.